HUTCHMED (China) Limited (HKG:0013)
23.35
-0.05 (-0.21%)
Apr 28, 2025, 4:08 PM HKT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
2.70M HKD
Profits / Employee
161.82K HKD
Market Cap
20.17B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Innovent Biologics | 5,659 |
Akeso | 3,035 |
Alibaba Health Information Technology | 1,435 |
Sino Biopharmaceutical | 24,379 |
HUTCHMED (China) News
- 4 days ago - HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 - GlobeNewsWire
- 5 days ago - AIM Market Roundup: Catenai, Seeen, Hutchmed - The Armchair Trader
- 6 days ago - HUTCHMED Completes Enrollment for Phase II Trial of Savolitinib in Gastric Cancer | HCM stock news - GuruFocus
- 6 days ago - HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China - GlobeNewsWire
- 14 days ago - Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war - South China Morning Post
- 5 weeks ago - HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma - GlobeNewsWire
- 5 weeks ago - Intended Retirement of Independent Non-executive Directors and changes of composition of board committees - GlobeNewsWire
- 5 weeks ago - US pharma restrictions won't affect Hutchmed operations, says CEO - CNBC